Robert W. Roth

676 total citations
30 papers, 489 citations indexed

About

Robert W. Roth is a scholar working on Organic Chemistry, Molecular Biology and Cancer Research. According to data from OpenAlex, Robert W. Roth has authored 30 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 12 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Robert W. Roth's work include Carcinogens and Genotoxicity Assessment (7 papers), Synthesis and Biological Evaluation (4 papers) and Analytical Chemistry and Chromatography (3 papers). Robert W. Roth is often cited by papers focused on Carcinogens and Genotoxicity Assessment (7 papers), Synthesis and Biological Evaluation (4 papers) and Analytical Chemistry and Chromatography (3 papers). Robert W. Roth collaborates with scholars based in United States. Robert W. Roth's co-authors include Ercole L. Cavalieri, Eleanor G. Rogan, Fred F. Kadlubar, Thomas J. Barton, Carl N. Martin, Frederick A. Beland, Alaeddin Hakam, Yasushi Yamazoe, John G. Verkade and Carter J. Grandjean and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Analytical Biochemistry.

In The Last Decade

Robert W. Roth

28 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert W. Roth United States 13 185 184 157 89 70 30 489
Gerhard Bonse Germany 13 218 1.2× 268 1.5× 144 0.9× 144 1.6× 157 2.2× 24 713
G.L. Kedderis United States 15 237 1.3× 163 0.9× 106 0.7× 80 0.9× 203 2.9× 20 730
Maurice M. Coombs United Kingdom 11 167 0.9× 160 0.9× 161 1.0× 68 0.8× 54 0.8× 51 479
G. Saint‐Ruf France 15 193 1.0× 146 0.8× 363 2.3× 126 1.4× 39 0.6× 64 697
D. M. Jerina United States 16 383 2.1× 298 1.6× 200 1.3× 103 1.2× 144 2.1× 30 702
J. Pataki United States 17 315 1.7× 180 1.0× 349 2.2× 74 0.8× 52 0.7× 51 753
Prabu Devanesan United States 11 362 2.0× 149 0.8× 98 0.6× 78 0.9× 58 0.8× 15 698
W. Griffith Humphreys United States 13 410 2.2× 198 1.1× 99 0.6× 96 1.1× 183 2.6× 17 849
Bengt Mannervik Sweden 16 376 2.0× 87 0.5× 63 0.4× 52 0.6× 65 0.9× 42 599
Martine Croisy‐Delcey France 12 186 1.0× 136 0.7× 238 1.5× 37 0.4× 83 1.2× 27 486

Countries citing papers authored by Robert W. Roth

Since Specialization
Citations

This map shows the geographic impact of Robert W. Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Roth more than expected).

Fields of papers citing papers by Robert W. Roth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Roth. The network helps show where Robert W. Roth may publish in the future.

Co-authorship network of co-authors of Robert W. Roth

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Roth. A scholar is included among the top collaborators of Robert W. Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Roth. Robert W. Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peterson, Lisa A., et al.. (2001). An improved synthesis of radiolabeled 4‐(acetoxymethylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone. Journal of Labelled Compounds and Radiopharmaceuticals. 44(6). 445–450. 5 indexed citations
2.
Howard, Harry, et al.. (1994). Synthesis of 3H‐ and 14C‐labelled CP‐88,059: A potent atypical antipsychotic agent. Journal of Labelled Compounds and Radiopharmaceuticals. 34(2). 117–125. 7 indexed citations
3.
Dow, Robert L., et al.. (1992). Synthesis of [19‐3H] herbimycin A. Journal of Labelled Compounds and Radiopharmaceuticals. 31(4). 333–339. 1 indexed citations
4.
Macor, John E., et al.. (1991). Synthesis of 5‐(2,3‐ditritiopropoxy)‐3‐(1,2,5,6‐tetrahydropyrid‐4‐yl)indole ([3H]CP‐96,501): A selective ligand for the serotonin (5‐HT1B) receptor. Journal of Labelled Compounds and Radiopharmaceuticals. 29(3). 249–257. 4 indexed citations
5.
Macor, John E., et al.. (1990). Synthesis of [3H]CP‐93,129: A selective radioligand for the 5‐HT1B receptor. Journal of Labelled Compounds and Radiopharmaceuticals. 28(11). 1293–1301. 3 indexed citations
6.
Roth, Robert W., et al.. (1988). Synthesis of D‐[1‐14C]penicillamine hydrochloride. Journal of Labelled Compounds and Radiopharmaceuticals. 25(11). 1177–1182.
7.
Roth, Robert W., et al.. (1987). Synthesis of 13C‐labeled polychlorinated biphenyls. Journal of Labelled Compounds and Radiopharmaceuticals. 24(2). 185–198. 2 indexed citations
8.
Rogan, Eleanor G., et al.. (1986). Mutagenicity of benzylic acetates, sulfates and bromides of polycyclic aromatic hydrocarbons. Chemico-Biological Interactions. 58(3). 253–275. 29 indexed citations
9.
McDonald, Jerome J., et al.. (1984). Synthesis and disposition of 14C-labelled gentian violet in F344 rats and B6C3F1 mice. Food and Chemical Toxicology. 22(5). 331–336. 3 indexed citations
10.
Fu, Peter P., Leonard E. Unruh, James P. Freeman, et al.. (1984). SYNTHESIS OF 6-SUBSTITUTED 3-DEUTEROBENZO[A]PYRENE. Organic Preparations and Procedures International. 16(3-4). 279–285. 1 indexed citations
11.
McDonald, Jerome J., et al.. (1984). Species and strain comparison of the metabolism of gentian violet by liver microsomes. Journal of Agricultural and Food Chemistry. 32(3). 596–600. 14 indexed citations
12.
Rogan, Eleanor G., et al.. (1980). Non-enzymatic ATP-mediated binding of hydroxymethyl derivatives of aromatic hydrocarbons to DNA. Chemico-Biological Interactions. 31(1). 51–63. 5 indexed citations
13.
Roth, Robert W., et al.. (1980). CONVENIENT SYNTHESES OF SELECTED14C- AND3H-LABELED AROMATIC HYDROXYLAMINES. Organic Preparations and Procedures International. 12(6). 337–344. 17 indexed citations
14.
Rogan, Eleanor G., et al.. (1978). Binding of benzo[a]pyrene and 3-methylcholanthrene to DNA by horseradish peroxidase. Federation Proceedings. 37(3). 1 indexed citations
15.
Rogan, Eleanor G., et al.. (1978). Binding of benzo[a]pyrene at the 1,3,6 positions to nucleic acids in vivo on mouse skin and in vitro with rat liver microsomes and nuclei. Chemico-Biological Interactions. 22(1). 35–51. 32 indexed citations
16.
Cavalieri, Ercole L., Robert W. Roth, Carter J. Grandjean, et al.. (1978). Carcinogenicity and metabolic profiles of 6-substituted benzo[a]pyrene derivatives on mouse skin. Chemico-Biological Interactions. 22(1). 53–67. 27 indexed citations
17.
Cavalieri, Ercole L., Robert W. Roth, J. Althoff, et al.. (1978). Carcinogenicity and metabolic profiles of 3-methylcholanthrene oxygenated derivatives at the 1 and 2 positions. Chemico-Biological Interactions. 22(1). 69–81. 24 indexed citations
18.
Barton, Thomas J., et al.. (1976). The photochemistry of 2-phenylselenophene and 2-phenyltellurophene. Journal of Organometallic Chemistry. 108(2). 183–195. 11 indexed citations
20.
Cavalieri, Ercole L. & Robert W. Roth. (1976). Reaction of methylbenzanthracenes and pyridine by one-electron oxidation. A model for metabolic activation and binding of carcinogenic aromatic hydrocarbons. The Journal of Organic Chemistry. 41(16). 2679–2684. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026